In the SURMOUNT-5 trial (NEJM, 2025), tirzepatide reduced body weight by 20.2% versus 13.7% for semaglutide over 72 weeks
and components of the pyruvate dehydrogenase (PDH) complexdihydrolipoamide S-acetyltransferase (DLAT), pyruvate dehydrogenase E1 subunit 1 (PDHA1), and pyruvate dehydrogenase E1 subunit (PDHB) (Figure 2) (Tsvetkov et al., 2022)
News Release October 26, 2010 ConsumerLab.com reports deficiencies in some B-complex supplements and more caffeine than expected in "shot-sized" B vitamin "energy" drinks White Plains, New York October 26, 2010 Tests of B vitamin supplements, including B-complexes and shot-sized energy drinks, revealed problems with the quality of 4 out of 18 products selected for review by independent testing organization ConsumerLab.com
Common Topical Application Patterns Use case Facial anti-aging (community use) Concentration 1-2% Frequency Once or twice daily Cycle length 8-12 weeks Use case Scalp / hair-research interest Concentration 1-3% Frequency Daily Cycle length 12+ weeks ongoing Use case Compounded post-procedure Concentration 1-2% Frequency Per clinician guidance Cycle length Per clinician guidance Topical concentrations are typically expressed as percent weight